SPH Decision on additional contribution to the capital of Sopharma Rus OOO
Sofia, Bulgaria, December 20, 2024 – In accordance with the requirements of Art. 100t of the LPOS, Sopharma AD (SFA: Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) hereby informs that in order to ensure operational opportunities for growth and increase sales on the traditional markets where the Company operates, the Board of Directors has decided to make an additional contribution to its subsidiary “Sopharma Rus” OOO in the amount of EUR 12.3 million, not increasing the capital.
Data | Tytuł | Kurs | Zmiana |
---|
2025-01-20 | SPH Sales revenues for December 2024 | 12,50 | +8,40 |
2025-01-15 | SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212 | 13,75 | -1,09 |
2025-01-02 | SPH Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024 | 12,25 | 0,00 |
2025-01-02 | SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD as of 27 December 2024 | 12,25 | 0,00 |
2024-12-23 | SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD | 12,25 | 0,00 |
2024-12-23 | SPH Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD | 12,25 | 0,00 |
2024-12-20 | SPH Notification from Alexander Tchaoushev in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD | 12,75 | 0,00 |
2024-12-20 | SPH Decision on additional contribution to the capital of Sopharma Rus OOO | 12,75 | 0,00 |
2024-12-19 | SPH Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma AD | 12,75 | 0,00 |
2024-12-19 | SPH Transaction within the scope of art. 114, para. 2 of the Law on Public offering of secirities | 12,75 | 0,00 |